Conditionally pathogenic genetic variants of a hematopoietic disease–suppressing enhancer-Reference-Cited by-同舟云学术

Conditionally pathogenic genetic variants of a hematopoietic disease–suppressing enhancer

Published:2021-12-10 Issue:50 Volume:7 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Soukup Alexandra A.¹²^ORCID,Matson Daniel R.¹²^ORCID,Liu Peng³,Johnson Kirby D.¹²^ORCID,Bresnick Emery H.¹²^ORCID

Affiliation:

1. Wisconsin Blood Cancer Research Institute, Department of Cell and Regenerative Biology, Wisconsin Institutes for Medical Research, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

2. UW Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

3. University of Wisconsin Carbone Cancer Center, Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Abstract

Noncoding genetic variants cause blood disease.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference63 articles.

1. Expanded encyclopaedias of DNA elements in the human and mouse genomes

2. Perspectives on ENCODE

3. Genetic predisposition to MDS: clinical features and clonal evolution

4. Transcription factor mutations as a cause of familial myeloid neoplasms

5. Germline mutations in MDS/AML predisposition disorders

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of immune cell interactions in alcohol-associated liver diseases;Liver Research;2024-06

2. Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program;Proceedings of the National Academy of Sciences;2024-02-29

3. Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia;Blood Advances;2023-12-28

4. Gata2 noncoding genetic variation as a determinant of hematopoietic stem/progenitor cell mobilization efficiency;Blood Advances;2023-12-15

5. Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy;Frontiers in Oncology;2023-06-12